Brandon Couillard
Stock Analyst at Wells Fargo
(4.44)
# 356
Out of 4,761 analysts
107
Total ratings
56.41%
Success rate
18.46%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Overweight | $415 → $420 | $380.81 | +10.29% | 3 | Feb 13, 2025 | |
| AVTR Avantor | Maintains: Overweight | $28 → $25 | $17.49 | +42.94% | 3 | Feb 10, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,350 → $1,400 | $1,303.13 | +7.43% | 3 | Feb 10, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $660 → $680 | $537.83 | +26.43% | 3 | Jan 31, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $280 → $240 | $207.95 | +15.41% | 2 | Jan 30, 2025 | |
| ALGN Align Technology | Maintains: Buy | $285 → $260 | $198.06 | +31.27% | 11 | Jan 23, 2025 | |
| HSIC Henry Schein | Maintains: Hold | $77 → $80 | $78.05 | +2.50% | 6 | Jan 23, 2025 | |
| CDNA CareDx | Upgrades: Equal-Weight | $28 → $24 | $23.38 | +2.65% | 2 | Jan 15, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $157 → $155 | $136.79 | +13.31% | 20 | Dec 9, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $84 → $85 | $49.51 | +71.68% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $75 | $52.92 | +41.72% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $34 → $75 | $101.58 | -26.17% | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $14.98 | +133.64% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $162.67 | +10.65% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $3.95 | +153.16% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $145.90 | -17.75% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $312.05 | +8.96% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $285.63 | +19.04% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $130 | $114.72 | +13.32% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $21.45 | +7.23% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.60 | +712.50% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.88 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $4.26 | +158.22% | 2 | Oct 13, 2017 |
Waters
Feb 13, 2025
Maintains: Overweight
Price Target: $415 → $420
Current: $380.81
Upside: +10.29%
Avantor
Feb 10, 2025
Maintains: Overweight
Price Target: $28 → $25
Current: $17.49
Upside: +42.94%
Mettler-Toledo International
Feb 10, 2025
Maintains: Equal-Weight
Price Target: $1,350 → $1,400
Current: $1,303.13
Upside: +7.43%
Thermo Fisher Scientific
Jan 31, 2025
Maintains: Overweight
Price Target: $660 → $680
Current: $537.83
Upside: +26.43%
Danaher
Jan 30, 2025
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $207.95
Upside: +15.41%
Align Technology
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $198.06
Upside: +31.27%
Henry Schein
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $78.05
Upside: +2.50%
CareDx
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $23.38
Upside: +2.65%
Agilent Technologies
Dec 9, 2024
Maintains: Overweight
Price Target: $157 → $155
Current: $136.79
Upside: +13.31%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $49.51
Upside: +71.68%
Nov 6, 2024
Maintains: Overweight
Price Target: $78 → $75
Current: $52.92
Upside: +41.72%
Oct 30, 2024
Maintains: Equal-Weight
Price Target: $34 → $75
Current: $101.58
Upside: -26.17%
Aug 27, 2024
Initiates: Overweight
Price Target: $35
Current: $14.98
Upside: +133.64%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $162.67
Upside: +10.65%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $3.95
Upside: +153.16%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $145.90
Upside: -17.75%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $312.05
Upside: +8.96%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $285.63
Upside: +19.04%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $130
Current: $114.72
Upside: +13.32%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $21.45
Upside: +7.23%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.60
Upside: +712.50%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.88
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $4.26
Upside: +158.22%